A Study of AL8326 in Healthy Subjects

Summary

This experiment plans to enroll 6-8 healthy male subjects in China, and ultimately collect complete test samples and data from at least 6 subjects as the standard. On the first day of the experiment, each subject orally took a single dose of \[14C\] AL8326 oral formulation containing approximately 60mg (200 μ Ci). During the experiment, whole blood, plasma, urine, and fecal samples were collected at designated time points/time periods.

Timeline

Start

2025-02-21

Primary completion

2025-05-17

Completion

2025-05-17

Drugs

Indications